Brief Introduction

SINOMED was founded in 2007 as a startup company searching for a way to improve the common coronary stent. Today, the company has become a publicly traded company on the Shanghai Stock Exchange STAR Market and it is one of the leaders in the Chinese coronary stent market. The headquarter of the company is located in Tianjin, China, with a 6,000 m2 class 10,000 cleanroom for manufacturing,quality control and development. Since its humble beginnings, SINOMED has worked closely with industry thought-leaders expanding its product offering to include a portfolio of coronary stents and balloons, as well as neurovascular and structural heart disease products.

We are devoted to becoming a global leader in medical devices, focusing on supporting healthcare professionals in their daily efforts to improve the lives of patients. We do this by continuing to evolve our technologies, focusing on quality in everything we do and striving to secure global access to our devices. At SINOMED, we are creating innovations for health.

Company Overview

Full name Sino Medical Sciences Technology Inc.
Abbreviations SINOMED
Code 688108
Founded Sept. 21st, 2007
Listing Oct. 30th, 2019
Domicile Tianjin
STAR Theme Manufacturing
CSRC Sector Biomedicine
Has weighted voting rights structure? No



  2020 2019 2018
Earnings Per Share 0.05 0.24 0.25
R&D expenditure as a % of operating revenue 48.62% 44.16% 34.17%
Operating Revenue 327.42 435.91 380.42
Net Income 22.49 90.04 89.19

Income Statement (Unit: RMB mn)

  2020 2019 2018
Operating Revenue 327.42 435.91 380.42
Operating Costs 310.32 329.83 279.87
Operating Income 24.01 108.58 108.34
Pretax Income 28.84 107.97 102.70
Income Tax 6.35 17.94 13.51
Net Income 22.49 90.04 89.19

Balance Sheet(Unit: RMB mn)

  2020 2019 2018
Current Assets-Total 723.43 806.88 535.37
Non-current Assets-Total 494.06 398.74 270.74
Total Assets 1,217.50 1,205.62 806.10
Current Liabilities-Total 92.18 79.18 83.08
Non-current Liabilities-Total 47.45 27.93 21.75
Total Liabilities 139.63 107.11 104.83
Stockholder's Equity
Share Capital 410.00 410.00 360.00
Retained Profits 667.87 688.51 341.28
Total Owners' Equity 1,077.87 1,098.51 701.28

Cash Flow Statement (Unit: RMB mn)

  2020 2019 2018
Net Cash Flows-Operating 70.51 137.61 97.56
Net Cash Flows-Investing -120.25 -178.09 162.60
Net Cash Flows-Financing -43.12 304.35 7.42

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
天津伟信阳光企业管理咨询有限公司 90.90 22.17%
Great Noble Investment Limited 57.78 14.09%
CSF Stent Limited 24.46 5.97%
LYFE Capital Blue Rocket (Hong Kong) Limited 21.70 5.29%
Decheng Capital ChinaLife Sciences USD Fund I, L.P. 20.23 4.93%
天津阳光广业企业管理合伙企业(有限合伙) 10.63 2.59%
Champ Star Technology Limited 8.96 2.19%
天津阳光德业企业管理合伙企业(有限合伙) 8.21 2.00%
31 Mar 2021

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.